DoH: Indemnity no link to Dengvaxia mess

The demand for indemnification agreements by Covid-19 vaccine manufacturers is not related to the Dengvaxia controversy, the Department of Health (DoH) said.

Health Undersecretary Maria Rosario Vergeire. Screengrab from DOH Beat COVID-19 Press Conference